To Surge or Not to Surge?
Experts Discuss Inclusion of a Surge Tank in an End-to-End Continuous Biomanufacturing Train
New Blood: Former Novartis Exec Transitions to Rubius Therapeutics
New Red-Blood-Cell-Derived Therapies Are Poised to Launch Rubius into the Spotlight.
Improving Human Health: The Promise of Epigenetics
A New Perspective for Genomic Research from Prof. Shankar Balsubramanian
Translating Innovation into Therapies
Antimicrobial Resistance and Drug Commercialization Were Key Topics at the Recent ON Helix Conference in Cambridge, U.K.
- STEMCELL Technologies
- 570 West Seventh Avenue
- Suite 400
- Vancouver BC, V5Z 1B3
STEMCELL Technologies is a privately-owned biotechnology company that develops specialty cell culture media, cell separation products and ancillary reagents for life science research. STEMCELL delivers over 1500 products to more than 70 countries worldwide.